Canada Markets closed

Salona Global Medical Device Corporation (LNDZF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.26250.0000 (0.00%)
At close: 12:28PM EDT

Salona Global Medical Device Corporation

3330 Caminito Daniella
Del Mar, CA 92014
United States
800 760 6826
https://www.salonaglobal.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees99

Key Executives

NameTitlePayExercisedYear Born
Mr. Leslie H. CrossExec. Chairman & Corp. Sec.103.62kN/A1951
Mr. Luke T. FaulstickCEO & Director203.29kN/A1964
Dr. Rick GreenwaldCo-Founder & Pres of SimbexN/AN/AN/A
Jeffrey ChuExec. OfficerN/AN/AN/A
Mr. Dennis T. NelsonChief Financial OfficerN/AN/A1973
Mr. Scott RogowVP of Sales & MarketingN/AN/AN/A
Mr. Jethro Rothe-KushelVP of Capital Markets & Financial CommunicationsN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Salona Global Medical Device Corporation, through its subsidiaries, engages in the production and sale of medical devices and products in the United States. The company's medical devices are used for pain management, cold and hot therapy, transcutaneous electronic nerve and neuromuscular electrical stimulation, pulsed electromagnetic field technology, and ultrasound therapy. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Brattle Street Investment Corp. and changed its name to Salona Global Medical Device Corporation in December 2020. Salona Global Medical Device Corporation was incorporated in 2013 and is headquartered in Del Mar, California.

Corporate Governance

Salona Global Medical Device Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.